Associated Papers
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes.
Thibaud S et al.
Blood Cancer Discovery, 2024
Association of XRCC2 with breast cancer, a multi-omics analysis at genomic, transcriptomic, and epigenomic level.
Gilani N et al.
Cellular and Molecular Biology (noisy-le-grand, France), 2024
XRCC2 (X-ray repair cross complementing 2).
Andreassen PR et al.
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2019
XRCC2 Regulates Replication Fork Progression during dNTP Alterations.
Saxena S et al.
Cell Reports, 2018
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers.
Golmard L et al.
European Journal of Human Genetics : Ejhg, 2017
Functional Analysis of Missense Variants in the Putative Breast Cancer Susceptibility Gene XRCC2.
Hilbers FS et al.
Human Mutation, 2016
Multigene testing of moderate-risk genes: be mindful of the missense.
Young EL et al.
Journal of Medical Genetics, 2016
26787654 (PubMed )
Supplement: jmedgenet-2015-103398-s2.pdf
Identification of novel hereditary cancer genes by whole exome sequencing.
Sokolenko AP et al.
Cancer Letters, 2015
Rare mutations in XRCC2 increase the risk of breast cancer.
Park DJ et al.
American Journal of Human Genetics, 2012
Select a paper to view details